Shot of a Lifetime

Our Products
Manufacturing-COVID19-Vaccine-01_790x500.png
Manufacturing-COVID19-Vaccine-01_1000x450.jpg

Shot of a Lifetime

How Pfizer and BioNTech Developed and Manufactured a COVID-19 Vaccine in Record Time

Raising Health Literate Children

Your Health
Health-Literacy-Children_380x500.png
Health-Literacy-Children_1000x450.jpg

Raising Health Literate Children

Why starting young can mean better health outcomes later in life.

Visit Our COVID-19 Hub

Our Science
GettyImages-1219398943_380x500.png
GettyImages-1219398943_1000x450.jpg

Visit Our COVID-19 Hub

What you need to know about the virus and updates on how Pfizer is responding to the crisis.

Cold, Flu, COVID-19, or Stomach Bug

Your Health
GettyImages-854418348_790x500.png
GettyImages-854418348_1000x450.jpg

Cold, Flu, COVID-19, or Stomach Bug

If you're feeling sick this fall, here's how to tell the difference between these common illnesses.

pfizer-logo
Your search for a clinical trial starts here.
Learn more about the process of joining a clinical trial and find a trial near you.

LEARN ABOUT OUR CLINICAL TRIAL FOR PEOPLE RECENTLY DIAGNOSED WITH COVID-19

Our Science
learn_about_our_clinical_trial_380x500_0.png
learn_about_our_clinical_trial_1000x450.jpg

LEARN ABOUT OUR CLINICAL TRIAL FOR PEOPLE RECENTLY DIAGNOSED WITH COVID-19

Do you have COVID-19? We are currently enrolling participants in a clinical trial for a potential oral treatment option.

The Truth About COVID-19 and "Black Fungus"

Your Health
Black-Fungus_790x500.jpg
Black-Fungus_1000x450.jpg

The Truth About COVID-19 and "Black Fungus"

Setting the record straight about a rare but fatal infection

Latest News

CHMP also recommends XELJANZ® (tofacitinib) approval for the treatment of adults with active ankylosing spondylitis Pfizer Inc. (NYSE: PFE) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the 100 mg and 200 mg doses of abrocitinib, an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for marketing authorization to treat moderate to severe atopic dermatitis (AD) in adults who are…